Jennifer Jarrett - Insider Trading & Ownership

Entity
Individual
Location
C/O Medivation, Inc., 525 Market St., 36 Th Floor, San Francisco, CA
Summary
The estimated net worth of Jennifer Jarrett is at least $4.62M dollars as of September 17, 2024. Jennifer Jarrett is the Chief Operating Officer of Arcus Biosciences, Inc. and owns shares of Arcus Biosciences, Inc. (RCUS) stock worth about $3.42M. Jennifer Jarrett is the Director of Syndax Pharmaceuticals Inc and owns shares of Syndax Pharmaceuticals Inc (SNDX) stock worth about $1.19M. Jennifer Jarrett is the Former Director of Surrozen, Inc./DE and owns shares of Surrozen, Inc./DE (SRZN) stock worth about $11.4K.
All Insider Reports
All Insider Reports

Ownership of Jennifer Jarrett

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RCUS Arcus Biosciences, Inc. Chief Operating Officer $3.42M -$2M -37% Sep 15, 2024
SNDX Syndax Pharmaceuticals Inc Director $1.19M Feb 7, 2024
SRZN, SRZNW Surrozen, Inc./DE Former Director $11.4K Aug 11, 2021
ARNA ARENA PHARMACEUTICALS INC Director Mar 11, 2022
RDUS Radius Health, Inc. Director Aug 15, 2022
SGMT Sagimet Biosciences Inc. Director Aug 1, 2024
ZURA Zura Bio Ltd Director May 18, 2023

Insider Transactions Reported by Jennifer Jarrett:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.